Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F1M59
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,132
Award facts
- Contract value 100% obligated
- $42,132.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $42,132.39 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on December 5, 2025, with completion scheduled for December 8, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. As the prime contractor under the SPE2DX IDC, the company supplies a comprehensive range of pharmaceutical products across multiple therapeutic domains to support Defense Health Agency initiatives and other government healthcare systems. The underlying IDC vehicle enables flexible pharmaceutical support globally, with DLA planning to establish multiple Pharmaceutical Prime Vendor Global Program Generation V contracts across separate regions. This delivery order for Otezla, a specialty pharmaceutical product, exemplifies the type of brand-name medication AmerisourceBergen routinely delivers through its federal contracts to meet military healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26F1M59?
SPE2DR26F1M59 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26F1M59 worth?
The government has obligated $42,132 on SPE2DR26F1M59.
Is contract SPE2DR26F1M59 an order under another contract?
Yes. SPE2DR26F1M59 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1M59 competed?
The extent of competition for SPE2DR26F1M59 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award